Stay updated with breaking news from Pharmaceutical Profiling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novel data in Alzstatin Alzheimer’s project presented at the 11th Pharmaceutical Profiling meetingAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule drug candidates for diseases affecting the central nervous system, with projects in both Alzhe...
STOCKHOLM, SWEDEN / ACCESSWIRE / January 27, 2022 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
STOCKHOLM, SWEDEN / ACCESSWIRE / January 4, 2022 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of small molecule
11th Annual PODD Drug Delivery Conference Announces 2021 Keynotes The Conference Forum is pleased to announce that the 11th annual PODD: Partnership Opportunities in Drug Delivery conference will take place in-person on October 28-29, 2021, at The Westin Boston Seaport District in Boston, MA. PODD brings together the R&D industry and the drug delivery community to figure out the best routes of delivering therapeutics and reducing the burden to patients. PODD 2021 kicks off with Barbara Lueckel, PhD, Global Head of Research Technologies Partnering, Roche Pharma Partnering, followed by Dr Rob...